About this trial
The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool improve lung cancer screening CT participation at 6 months after the baseline outpatient visit?
The intervention is an alert to the provider to discuss lung cancer screening CT eligibility, for patients considered at high risk of lung cancer based on CXR-LC AI tool. Intervention and non-intervention arms will be compared to determine if lung cancer screening CT participation increases.
Individuals who are considered high-risk by the tool, but who do not meet the Medicare/USPSTF pack-year or quit-date lung screening eligibility criteria may be offered research lung screening CT.
Eligibility criteria
Qualifiers
Scheduled outpatient appointment with participating provider.
50- to 77-year-old who currently or formerly smoked, to include persons potentially eligible for lung screening based on Medicare guidelines.
Recent (within 2 years) PA chest radiograph.
Disqualifiers
None
Trial design
Treatments tested in this trial
- CXR-LC
Treatment groups
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
Harvard Risk Management Foundation
Collaborator